Re: Chapple CR, Martinez-Garcia R, Selvaggi L, Toozs-Hobson P, Warnack W, Drogendijk T, Wright DM, Bolodeoku J. A Comparison of the Efficacy and Tolerability of Solifenacin Succinate and Extended Release Tolterodine at Treating Overactive Bladder Syndrome: Results of the STAR trial. Eur Urol 2005;48:464–70

2006 ◽  
Vol 49 (1) ◽  
pp. 187-188 ◽  
Author(s):  
Udo Jonas ◽  
Raymond R. Rackley
Keyword(s):  
Overactive Bladder ◽  
Extended Release ◽  
Overactive Bladder Syndrome ◽  
Solifenacin Succinate ◽  
Star Trial

scholarly journals Comparison of the efficacy of Solifenacin Succinate and Tolterodine for the treatment of overactive bladder syndrome

2017 ◽  
Vol 8 (2) ◽  
pp. 231-234
Author(s):  
Mohammad Monsur Hallaz ◽  
BH Nazma Yasmeen ◽  
Nadia Sultana ◽  
Mahfuza Akter ◽  
Nurul Alam Basher
Keyword(s):  
Overactive Bladder ◽  
Extended Release ◽  
Private Hospital ◽  
Overactive Bladder Syndrome ◽  
College Hospital ◽  
Medical College ◽  
Release Preparation ◽  
Solifenacin Succinate ◽  
Randomized Control ◽  
New Generation

Background : Overactive Bladder Syndrome(OAB) is not an uncommon problem. Although exact incidence of this disease in our country is not known but a significant number of people suffering from this disease seek treatment at the Urology department of different hospitals. At present two common antimuscarinic drug Solifenacin Succinate and Tolterodine are available in our country for the treatment of OAB.Objective : To compare the efficacy of Solifenacin Succinate and Tolterodine to treat OAB.Methodology : This hospital based randomized control trial was conducted in the Department of Urology, Dhaka Medical College Hospital, Dhaka and a private hospital from January 2009 to December 2010 to compare the efficacy of two new generation antimuscarinics, Solifenacin succinate and Tolterodine at their recommended doses for the treatment of OAB.Results : After 3 months of treatment it has clearly shown that Solifenacin is more effective in reducing OAB symptoms compared with extended release preparation of Tolterodine. This include statistically significant reduction in episodes of frequency, urgency, urge incontinence, nocturia and significant improvement of voided volume.Northern International Medical College Journal Vol.8(2) January 2017: 231-234

Trospium chloride extended release is effective and well tolerated in women with overactive bladder syndrome

2009 ◽  
Vol 20 (12) ◽  
pp. 1431-1438 ◽  
Author(s):  
Peter K. Sand ◽  
Roger R. Dmochowski ◽  
Norman R. Zinner ◽  
David R. Staskin ◽  
Rodney A. Appell
Keyword(s):  
Overactive Bladder ◽  
Extended Release ◽  
Overactive Bladder Syndrome ◽  
Trospium Chloride
Sign in / Sign up

Export Citation Format

Share Document